HYPEREOSINOPHILIC SYNDROME
Clinical trials for HYPEREOSINOPHILIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new HYPEREOSINOPHILIC SYNDROME trials appear
Sign up with your email to follow new studies for HYPEREOSINOPHILIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with rare blood disorder: drug cuts flares and steroid use
Disease control CompletedThis study tested a drug called mepolizumab in 16 children aged 6 to 17 with hypereosinophilic syndrome (HES), a rare condition where too many white blood cells cause damage. The goal was to see if the drug could reduce disease flares and the need for steroids. Over 52 weeks, mos…
Matched conditions: HYPEREOSINOPHILIC SYNDROME
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
Drug dasatinib shows promise for rare blood cancers
Disease control CompletedThis study tested the drug dasatinib in 68 adults with several blood and bone marrow disorders, including certain leukemias, myelofibrosis, and mastocytosis. The goal was to see if dasatinib could help control these diseases and to check its safety. Results focused on how many pa…
Matched conditions: HYPEREOSINOPHILIC SYNDROME
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 18, 2026 11:59 UTC
-
Scientists hunt for clues to diagnose rare blood disorder
Knowledge-focused CompletedThis study aimed to find new biological markers (biomarkers) that can help doctors diagnose hypereosinophilic syndrome (HES) more easily and accurately. Researchers used a technique called proteomics to analyze samples from 41 participants. The goal was to improve diagnosis by di…
Matched conditions: HYPEREOSINOPHILIC SYNDROME
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated May 26, 2026 07:58 UTC